• Please log in or register to access this feature.

Special Article

You have full text access to this OnlineOpen article

Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27–March 1, 2003

  1. Jean-Michel Pawlotsky1,
  2. John G. McHutchison2,†,*

Article first published online: 30 JAN 2004

DOI: 10.1002/hep.20065

Issue

Hepatology

Hepatology

Volume 39, Issue 2, pages 554–567, February 2004

Additional Information

How to Cite

Pawlotsky, J.-M. and McHutchison, J. G. (2004), Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27–March 1, 2003. Hepatology, 39: 554–567. doi: 10.1002/hep.20065

Author Information

  1. 1

    Department of Virology (EA 3489), Henri Mondor Hospital, University of Paris XII, Créteil, France

  2. 2

    Duke Clinical Research Institute, Duke University Clinical Center, Durham, NC

  1. †

    fax: 919-668-7164

*Duke Clinical Research Institute and Division of Gastroenterology, Duke University Medical Center, Durham, NC 27705

  1. †

    fax: 919-668-7164

Publication History

  1. Issue published online: 30 JAN 2004
  2. Article first published online: 30 JAN 2004
  3. Manuscript Accepted: 15 OCT 2003
  4. Manuscript Received: 10 OCT 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS